NIH-funded research R01 grant

Alcohol and DNA repair: how acetaldehyde speeds cancer from alcohol use

Official title: Novel Insights into Alcohol-Driven Tumorigenesis via Ribosomal Suppression and DNA Repair Dysregulation

Funded at Univ of North Carolina Chapel Hill · NIH-11418275 · Data updated 2026-11-12

A new NIH grant is exploring how alcohol-related DNA damage and ribosome problems may drive oral cancer, with potential to help people who drink alcohol.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startAugust 5, 2026
Project endJuly 31, 2030
Funding year2026
Award (this year)$2,763,805
NIH project number1R01AA033309-01
Project IDNIH-11418275 on NIH RePORTER

Who could benefit from this research

Could help

People who consume alcohol and are at risk for oral cancer may be relevant for future studies or related trials.

Less likely to help

Individuals with no exposure to alcohol or oral cancer risk factors may not benefit directly from this basic mechanistic work.

What this research studies

Researchers at the University of North Carolina-Chapel Hill are studying how the carcinogen acetaldehyde from alcohol affects cells, including how it slows ribosome function and disrupts DNA repair. The project looks at why drinking alcohol increases risk for oral squamous cell carcinoma and aims to uncover mechanisms that could lead to better prevention. The work involves laboratory studies with human-relevant models to understand how early changes in protein production and repair pathways contribute to cancer development. Findings could point toward targeted prevention strategies or biomarkers for identifying individuals at higher risk.

Why it matters

Potential benefit: If successful, the research could lead to new ways to prevent alcohol-related oral cancer or identify people at higher risk earlier.

How similar studies have gone: Previous work has linked acetaldehyde to DNA damage and cancer risk, with ongoing exploration of ribosome and repair pathway interactions; this study builds on those insights with a focus on oral cancer.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Peng, Aimin — Univ of North Carolina Chapel Hill
  • Study coordinator: Peng, Aimin

Related research

Other NIH-funded projects on the same topics.

  • A center for coordinating data related to heart and blood health.

    This study is working on a new system to gather and analyze health information about heart and blood disorders, which could lead to better ways to diagnose and treat these conditions, ultimately helping patients like you.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-9732880

  • Healthy work design and worker well-being

    A multi-site program aims to improve the health and well-being of workers by studying how work design affects safety, stress, and quality of life.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11631666

  • Unified and fair multimodal learning for autoimmune diseases

    A patient-friendly AI approach will combine many kinds of health data to improve diagnosis and personalized care for autoimmune diseases, including lupus.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11625649

  • Structural factors linking minimum wage, COVID-19, and community violence

    A long-term study will explore whether higher minimum wages and pandemic-related economic factors are connected to changes in violence in US communities.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11624218

  • Non-invasive tears biomarker for early Alzheimer's in LMICs

    A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11623923

  • How HPV interacts with our cells' DNA damage system and its effect on cancer

    This project looks at how high-risk HPV uses the body’s DNA repair machinery to replicate and potentially drive cancer, with the goal of finding new antiviral and cancer-fighting approaches for people affected by HPV-related diseases.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11622604

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.